Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 4:50 AM
Ignite Modification Date: 2025-12-26 @ 3:51 AM
NCT ID: NCT02998918
Description: None
Frequency Threshold: 0
Time Frame: Adverse event data were collected from the start of the study until 4 weeks later.
Study: NCT02998918
Study Brief: Effects of Short-term Curcumin and Multi-polyphenol Supplementation on the Anti-inflammatory Properties of HDL
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
PolyResveratrol Supplementation 1 mg/day (one dose of 500 mg/two capsules in morning and two capsules/500 mg at night) of Polyresveratrol-SR for one week 0 None 0 21 0 21 View
Curcumin Supplementation 1 mg/day (one dose of 500 mg/two capsules in morning and two capsules/500 mg at night) of Meriva 500-SF (curcumin phytosome) for one week 0 None 0 20 0 20 View
Serious Events(If Any):
Other Events(If Any):